Literature DB >> 6466144

Demonstration of antibody and cellular immune response to brain extract in West and Lennox-Gastaut syndromes.

N G Mota, M T Rezkallah-Iwasso, M T Peraçoli, T C Montelli.   

Abstract

We investigated humoral and cellular immune response to brain tissues in 15 patients with West syndrome, in 9 patients with Lennox-Gastaut syndrome and in 20 healthy children. High levels of a precipitating antibody to a saline extract of brain tissue were detected in all patients; leucocyte migration inhibition test with the same antigen was found to be positive in most of them. The role of this autoimmune response in the pathogenesis of West and Lennox-Gastaut syndromes remains to the elucidated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466144     DOI: 10.1590/s0004-282x1984000200004

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  5 in total

Review 1.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

2.  Use of intravenous immunoglobulins in drug-resistant epilepsy.

Authors:  A Fois; M Vascotto
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

Review 3.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 4.  Immunoglobulin treatment in human and experimental epilepsy.

Authors:  B G van Engelen; W O Renier; C M Weemaes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

5.  Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy.

Authors:  Melissa L Barker-Haliski; Wolfgang Löscher; H Steve White; Aristea S Galanopoulou
Journal:  Epilepsia       Date:  2017-07       Impact factor: 6.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.